From: Autophagy-associated circRNA circCDYL augments autophagy and promotes breast cancer progression
 | Number of patients | Total | P value | |
---|---|---|---|---|
Low circCDYL | High circCDYL | |||
Age | Â | Â | Â | 0.728 |
 >35 | 50 | 52 | 102 |  |
  ≤ 35 | 6 | 5 | 11 |  |
Menopause | Â | Â | Â | 0.644 |
 Yes | 35 | 38 | 73 |  |
 No | 21 | 19 | 40 |  |
ER status | Â | Â | Â | 0.035 |
 Negative | 14 | 25 | 39 |  |
 Positive | 42 | 32 | 74 |  |
PR status | Â | Â | Â | 0.106 |
 Negative | 30 | 39 | 69 |  |
 Positive | 26 | 18 | 44 |  |
HER2 status | Â | Â | Â | 0.20 |
 Negative | 38 | 32 | 70 |  |
 Positive | 18 | 25 | 43 |  |
Ki67 Level | Â | Â | Â | < 0.0001 |
 Low | 48 | 20 | 68 |  |
 High | 8 | 37 | 45 |  |
Molecular subtype | Â | Â | Â | 0.102 |
 Luminal | 42 | 32 | 74 |  |
 HER2+ | 7 | 11 | 18 |  |
 TNBC | 7 | 14 | 21 |  |
Tumor stage | Â | Â | Â | 0.001 |
 T1 | 27 | 11 | 38 |  |
 T2 | 23 | 28 | 51 |  |
 T3–4 | 6 | 18 | 24 |  |
Lymphatic stage | Â | Â | Â | 0.046 |
 N0 | 28 | 17 | 45 |  |
 N1 | 16 | 17 | 33 |  |
 N2–3 | 12 | 23 | 35 |  |